Showing results (371-380 of 1,002) with videos related to
Sort By:
Pageof 101
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.Ejhaem|July 18, 2022
GDF-15 is associated with atherosclerosis in adults with transfusion-dependent beta-thalassemiaAlaa Efat, Rana Wahb, Sabry Abd Allah Shoeib, et al.Ejhaem|July 18, 2022
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLLNarjis Fatima, Yandong Shen, Kyle Crassini, et al.Ejhaem|July 18, 2022
Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case seriesLeila Motedayen Aval, Mary Boullier, Hermione Lyall, et al.Ejhaem|July 18, 2022
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial)Heinz Ludwig, Bela Hausmann, Martin Schreder, et al.Ejhaem|July 18, 2022
High serum ferritin alone as a predictor of mortality and hemophagocytic lymphohistiocytosisShruti Kohli, Ritu Chadha, Neha Rastogi, et al.Ejhaem|July 18, 2022
Redefining the high-grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case reportSocorro María Rodríguez-Pinilla, Rocío Nieves Salgado, Cristina Chamizo, et al.Ejhaem|July 18, 2022
Complement activation during cardiopulmonary bypass and association with clinical outcomesRengina Kefalogianni, Farah Kamani, Mihaela Gaspar, et al.Ejhaem|July 18, 2022
Iron, neuro-bioavailability and depressionChristian Berthou, Jean Paul Iliou, Denis BarbaEjhaem|July 18, 2022
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myelomaThomas Martin, Amrita Krishnan, Kwee Yong, et al.Pageof 101